Investor Relations
Events
Precigen Business and Pipeline Update Call
Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients and a wholly owned subsidiary of Intrexon, hosted a conference call November 12th, 2019, at 11:00 AM ET to provide Precigen business and pipeline updates. A replay of the webcast may be acccessed through Intrexon’s website in the Investors section at http://investors.dna.com/events or Precigen’s website in the Presentations section at https://precigen.com/media/#id-presentations.
